spacer.gif spacer.gif spacer.gif spacer.gif spacer.gif spacer.gif spacer.gif spacer.gif spacer.gif
HeaderLeft.gif HeaderTop3.gif HeaderTop2.gif spacer.gif
Jan 28, 2012 - 06:56 PM  
HeaderLeft.gif
spacer.gif spacer.gif spacer.gif
BannerTop.gif HeaderEye.gif spacer.gif
BannerLeft.jpg BannerRight.jpg spacer.gif
BannerBott.jpg spacer.gif
HeaderBottbg.jpg spacer.gif
Languages
Preferred language:

English

News Categories

Main Menu

Search Box


Login




 


 Log in Problems?
 New User? Sign Up!

Online
There are 2 unlogged users and 0 registered users online.

You can log-in or register for a user account here.

Welcome to the Genetic Epidemiology Network

The Genetic Epidemiology Network (GeEpNet) is a multidisciplinary research and education network in the field of Genetic Epidemiology formed in 2003 within the Aristotle University of Thessaloniki. Genetic Epidemiology is an emerging field in Medical research with increasing interest especially after the completion of the Human Genome project. Genetic epidemiological research focuses on complex diseases and addresses the relationship between genetic factors and risk of disease, in particular in relation to gene-gene and gene-environment interactions.
Research is organized in three main settings. In the first setting population-based studies are performed. Main focus of the first research setting will be to define disease phenotypes to develop phenotyping protocols and to classify patients in the different phenotypes of a disease. The GeEpNet includes research in the frame of the Thessaloniki Eye Study, which is a large population-based study of glaucoma and age-related macular degeneration. Family studies are included in the population-based Thessaloniki Eye Study.
In the second setting research aims to identify new genetic factors involved in complex diseases using family as well as population-based approaches. Studies using linkage and sibpair analysis are to be planned and will include neurological diseases, cardiovascular diseases, hematologic disorders, cancer, ophthalmic diseases and metabolic diseases.
The second setting also includes development and application of molecular methods for genetic and epigenetic analysis in the frame of the population based studies mentioned above. According to the subject of each population-based study, specific markers for the investigation of disease-related loci ( polymorphisms and genes ) are going to be selected for genotyping .
In the third setting, genotyping results will be compared with disease phenotypes and submitted to linkage analysis (sibpairs within families), in order to reveal possible associations between the two sets of parameters. Identified genotypes strongly associated with disease will be further investigated in the functional setting.
The multidisciplinary approach in genetic epidemiology research includes molecular biologists and molecular approaches in Genetics for Clinicians and Epidemiologists.


Contact points:

Research Laboratory in Ophthalmology:
Fotis Topouzis, MD
Phone: (+30)2310994920, (+30)2310994913
email:odrlab@med.auth.gr



spacer.gif
spacer.gif   Age-related Macular Degeneration
Posted by: Admin on Tuesday, May 25, 2004 - 02:05 PM
  spacer.gif
  AMD
1493 Reads

Despite numerous references in the ophthalmic literature dating more than 80 years ago, the genetic basis of age-related macular degeneration (AMD) has only recently received focused attention from both the ophthalmology and genetics communities. This attention has largely been due to the growing awareness of the role of genetics for a number of complex, late-onset medical disorders and the development of new tools that allow us to define the genetic loci that contribute to disease susceptibility.



 
spacer.gif
spacer.gif spacer.gif spacer.gif spacer.gif

spacer.gif
spacer.gif   Glaucoma
Posted by: Admin on Tuesday, May 25, 2004 - 10:25 AM
  spacer.gif
  Glaucoma
1599 Reads

Glaucoma is a term used to describe a group of heterogeneous conditions that share in common a chronic progressive optic neuropathy. Glaucomatous optic neuropathy is characterised by structural changes in the optic nerve head and associated visual field loss. Glaucoma is the leading cause of preventable irreversible blindness worldwide1. Approximately 4% of white subjects with glaucoma and 8% of black subjects are bilaterally blind. It has been estimated that approximately 6.7 million people are bilaterally blind from glaucoma, while 15% of the total burden of world blindness is due to this disease2. The condition is frequently diagnosed late (by which time the prognosis has worsened) and the proportion of undiagnosed cases (even in Western countries) is estimated to be ~50%3.

 
spacer.gif
spacer.gif spacer.gif spacer.gif spacer.gif

spacer.gif
spacer.gif   Conferences: 2nd Summer School on Emerging Technologies in Biomedicine
Posted by: ioannaCh on Monday, May 17, 2004 - 02:19 PM
  spacer.gif
  News
1559 Reads

2nd Summer School on Emerging Technologies, Patras 20-25 June 2005
4th European Symposium on Biomedical Engineering, Patras 25-27 June 2005
http://bme.med.upatras.gr/patras2004


 
spacer.gif
spacer.gif spacer.gif spacer.gif spacer.gif

spacer.gif spacer.gif spacer.gif spacer.gif spacer.gif
BlockRTop.gif spacer.gif RC_Logo_supported_by_EN.gif
  Other Stories

  spacer.gif
BlockRBott.gif spacer.gif spacer

Footerdot.gif
Genetic Epidemiology Network